ReviewMicroorganisms2015

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5.

Annemarie Baars et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.